Solazyme Surges 15% in Nasdaq Debut on Alternative Fuels Bet
Solazyme Inc., the developer of oil products from genetically modified algae, jumped 15 percent in its first day of trading on increasing demand for renewable sources of fuel and specialty chemicals. [...] A key question, [Pavel Molchanov, an analyst for Raymond James & Associates Inc.] said, is whether Solazyme, or rivals that are developing similar products such as Gevo Inc., and Amyris Inc., can do so cost-effectively.
Reacties
Er zijn nog geen reacties op dit bericht